
Cognitive-Behavioral Therapy for the Treatment of Depression and Adherence in Patients With Type 1 Diabetes
Author(s) -
Sarah Markowitz,
Matthew M. Carper,
Jeffrey S. Gonzalez,
Linda M. Delahanty,
Steven A. Safren
Publication year - 2012
Publication title -
primary care companion to cns disorders/the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.328
H-Index - 50
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.11m01220
Subject(s) - medicine , depression (economics) , type 2 diabetes , diabetes mellitus , montgomery–åsberg depression rating scale , cognitive behavioral therapy , rating scale , physical therapy , major depressive disorder , psychiatry , anxiety , cognition , psychology , developmental psychology , economics , macroeconomics , endocrinology
Depression is one of the most common psychological problems affecting individuals with type 1 diabetes, and it is associated with treatment nonadherence and worse clinical outcomes. The research on treating depression or nonadherence in adults with type 1 diabetes is limited. We adapted an evidence-supported treatment, individual cognitive-behavioral therapy for adherence and depression (CBT-AD), for type 1 diabetes and examined its feasibility, acceptability, and potential for an effect.